Excelsior Medical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 11, 2023 at 03:45 am EDT
Share
Excelsior Medical Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 2,022.41 million compared to TWD 1,674.29 million a year ago. Net income was TWD 173.08 million compared to TWD 140.18 million a year ago. Basic earnings per share from continuing operations was TWD 1.1143 compared to TWD 0.9048 a year ago. Diluted earnings per share from continuing operations was TWD 1.1143 compared to TWD 0.8952 a year ago.
For the six months, sales was TWD 4,028.82 million compared to TWD 3,382.62 million a year ago. Net income was TWD 374.9 million compared to TWD 308.12 million a year ago. Basic earnings per share from continuing operations was TWD 2.4095 compared to TWD 1.981 a year ago. Diluted earnings per share from continuing operations was TWD 2.4 compared to TWD 1.9714 a year ago.
EXCELSIOR MEDICAL CO., LTD. is a Taiwan-based company principally engaged in the distribution, maintenance and leasing of medical equipment and supplies. The Companyâs principal products include artificial kidneys, hemodialysis blood tubing sets and epidural needles, dialysis liquid medicines and powder medicines, dialysis machines, human erythropoietin, surgery consumable materials, blood bags, plasma replacement machines and beauty medical equipment, among others. The Company is also involved in the production and sales of self-owned soybean milk machines, as well as household air fresheners under the brand name of Coway. The Company mainly operates its businesses in domestic market and overseas markets.